Erik G. Lund
Department of Cardiovascular Diseases
Merck Research Laboratories
Merck & Co.
Inc., RY80W-250
United States
Name/email consistency: high
- Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype. Lund, E.G., Peterson, L.B., Adams, A.D., Lam, M.H., Burton, C.A., Chin, J., Guo, Q., Huang, S., Latham, M., Lopez, J.C., Menke, J.G., Milot, D.P., Mitnaul, L.J., Rex-Rabe, S.E., Rosa, R.L., Tian, J.Y., Wright, S.D., Sparrow, C.P. Biochem. Pharmacol. (2006)
- Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis. Lund, E.G., Menke, J.G., Sparrow, C.P. Arterioscler. Thromb. Vasc. Biol. (2003)